Search for: "Laurence" Results 581 - 600 of 3,325
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jun 2021, 5:01 am by Kluwer Patent blogger
” More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und… [read post]
Input by: Alejandro Luna (OLIVARES) More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 … [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und internationales… [read post]
http://wolterskluwerblogs.com/competition/wp-content/uploads/sites/51/2021/06/KLI-11-trailer.mp4 More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€… [read post]
2 Jun 2021, 11:30 am by Iorio Altamirano
The Financial Industry Regulatory Authority’s Department of Enforcement has filed a disciplinary proceeding complaint against brokerage firm NYPPEX, LLC (CRD No. 47654), Former Chief Executive Officer (“CEO”) Laurence Allen (CRD No. 1063970), and Chief Compliance Officer (“CCO”) Michael Schunk (CRD No. 732595). [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und internationales… [read post]
27 May 2021, 12:45 pm by Miquel Montañá (Clifford Chance)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und internationales… [read post]
26 May 2021, 7:31 am by Adrian Crespo (Clifford Chance)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und internationales… [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und internationales… [read post]
22 May 2021, 2:07 am by Kluwer Patent blogger
Although second medical use protection has had limited importance in the treatment of COVID-19, it has put in the spotlight the overall need for quick reactions to new diseases, which is one of the many factors justifying such protection, according to Jochen Bühling, partner of the German law firm of Krieger Mes & Graf v. der Groeben and editor of ‘Patent Protection for Second Medical Uses’. [read post]
20 May 2021, 5:02 am by Thorsten Bausch (Hoffmann Eitle)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und internationales… [read post]
20 May 2021, 3:20 am by Matthieu Dhenne (Ipsilon)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Europäisches und internationales… [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for Innovation … [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for Innovation … [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for Innovation … [read post]
15 May 2021, 9:07 am by Bryce Klehm, Rohini Kurup, Matt Gluck
  Laurence Helfer and Molly Land argued that comparing the Facebook Oversight Board to an international human rights tribunal illustrates that the board’s ability to meaningfully impact Facebook’s behavior will depend on how well it develops human rights norms, whether Facebook meaningfully accepts those norms and how successful the board is in overcoming challenges to its position as an authoritative body. [read post]
14 May 2021, 1:18 pm by Matt Gluck
Laurence Heifer and Molly Land argued that comparing the Facebook Oversight Board to an international human rights tribunal demonstrates that the board’s ability to hold Facebook accountable is dependent on whether it can develop human rights norms and convince [read post]